Live Breaking News & Updates on Imerli

Stay informed with the latest breaking news from Imerli on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Imerli and stay connected to the pulse of your community

Coherus to divest ophthalmology business for $170M

"Coherus BioSciences to divest ophthalmology franchise, Cimerli, to Sandoz for $170 million. Deal includes product inventory and access to commercial software

Coherus-biosciences , Meta-keywords-biopharmaceutical , Oherus-biosciences , Ivest , Phthalmology-franchise , Andoz , 70-million , Imerli , Roduct-inventory ,

Sandoz To Acquire CIMERLI Business From Coherus

Sandoz has signed an agreement to acquire the US biosimilar ranibizumab CIMERLI from Coherus BioSciences, Inc. for an upfront cash purchase payment of $170 million.

Nasdaq , Us-consumer-product-safety-commission , Robot-corp , Steamist-inc , European-union , State-street , Product-safety-commission , Bokser-home , New-jersey-based-steamist , Sandoz , Oherus-